This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

David A. Kessler, MD, JD; Wayne L. Pines

JAMA. 1990;264(18):2409-2415.

Abstract
Prescription drug advertising has been regulated by the Food and Drug Administration since 1962. In the past decade, pharmaceutical companies have employed new communication mechanisms to reach physicians and, with increasing frequency, consumers. Examples of physician-oriented promotional activities are medical symposia and teleconferences. Consumer-oriented efforts include press conferences, use of celebrity spokespeople, and direct-to-consumer advertising. The Food and Drug Administration has asserted its legal jurisdiction over these nontraditional promotional activities and is regulating them on a case-by-case basis. As nontraditional promotional efforts become more prevalent, the Food and Drug Administration's regulatory framework must be able to meet the challenges of a changing environment.

(JAMA. 1990;264:2409-2415)

Author Affiliations
From the Jack D. Weiler Hospital of the Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY (Dr Kessler), and Burson-Marsteller, Washington, DC (Mr Pines). Mr Pines served as Associate Commissioner for Public Affairs at the Food and Drug Administration from 1978 to 1982 and currently advises pharmaceutical clients in his role at Burson-Marsteller.

Footnotes
This article was written, submitted, and accepted for publication before Dr Kessler was nominated to be Commissioner of the Food and Drug Administration.

Reprint requests to the Jack D. Weiler Hospital of the Albert Einstein College of Medicine, 1825 Eastchester Rd, Bronx, NY 10461 (Dr Kessler).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

"Your Life is Waiting!": Symbolic Meanings in Direct-to-Consumer Antidepressant Advertising
Grow et al.
Journal of Communication Inquiry 2006;30:163-188.
ABSTRACT  

Advertising by Academic Medical Centers
Larson et al.
Arch Intern Med 2005;165:645-651.
ABSTRACT | FULL TEXT  

The Educational Potential Of Direct-To-Consumer Prescription Drug Advertising
Kaphingst and DeJong
Health Aff (Millwood) 2004;23:143-150.
ABSTRACT | FULL TEXT  

Evidence-Based And Value-Based Formulary Guidelines
Neumann
Health Aff (Millwood) 2004;23:124-134.
ABSTRACT | FULL TEXT  

The Impact of a Celebrity Promotional Campaign on the Use of Colon Cancer Screening: The Katie Couric Effect
Cram et al.
Arch Intern Med 2003;163:1601-1605.
ABSTRACT | FULL TEXT  

Use of Trade Names of Drugs and the Scientific Content of Medical Congresses
Ripamonti et al.
JCO 2002;20:1707-1708.
FULL TEXT  

The Rise of Direct-to-Consumer Advertising of Prescription Drugs in the United States
Huang
JAMA 2000;284:2240-2240.
FULL TEXT  

The PDR Is Food and Drug Administation-Approved Labeling
Oddis
Arch Intern Med 1997;157:576-579.
ABSTRACT  

The FDA and Drug Marketing Expenditures
Joseph
JAMA 1991;265:1528-1528.
ABSTRACT  

FDA Regulation of Prescription Drug Advertising
Peck and Rheinstein
JAMA 1990;264:2424-2425.
ABSTRACT